The Therapeutic Goods Administration grants provisional approval for Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug. (News.com.au) COVID-19 drug developmentCOVID-19 pandemic in AustraliaCOVID-19 pandemic link embed save